Exosens & Senop Partnership

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes highlighting increasing demand for night vision goggles

PRESS RELEASE
MÉRIGNAC, FRANCE – FEBRUARY, 24th 2025

  • Exosens announces that Senop, a Finnish provider of high-tech optronic solutions including night vision goggles, has placed several significant orders for its Photonis white phosphor 4G intensifier tubes, to be delivered over 2025.
  • Third contracts signed with Senop since 2021 confirming Exosens position as the strategic supplier of image intensifier tubes for Baltic and Nordic countries underscoring the potential for material new sales in this area.
  • Rising demand for Night Vision goggles driven by increased military budgets and demonstrated criticality of night vision.
  • Exosens continue to fully benefit from this increasing demand as the strategic supplier of image intensifier tubes to NATO member states and their allies.

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes.

Exosens, announces the signature of new contract with Senop, a Finnish provider of high-tech optronic solutions including night vision goggles (NVGs). Several major orders for Photonis (Exosens’ brand) white phosphor 4G intensifier tubes, have been placed and will be delivered throughout 2025.

This is the third contract with Senop since 2021, after Exosens supplied a first batch of Photonis 4G image intensifiers with white phosphor screens for Senop's EVA NVGs. A large order followed in 2022, and now, a third contract for the new EVA M development for an undisclosed customer.

The new Senop EVA M is a compact night vision device for dismounted soldiers that enables mobile low-light combat including last features and usability improvements based on findings from user experiences in recent conflicts. 

Rising night vision market driven by increased military budgets and demonstrated criticality of night vision in high-intensity warfare

The increase of night vision capabilities has become a strategic priority for many nations due to recent geopolitical challenges, such as the 2022 invasion of Ukraine, which emphasized night vision criticality on the battlefield. The night vision market is fully benefitting from increased defense budgets since 2022, with the European Union seeing an average 6% rise in military spending, and countries like Sweden boosting their budgets by over 30%.

Baltic and Nordic regions are even more exposed to military spending increase given geopolitical context in the region. Many countries are modernizing their defense capabilities, with a specific focus on improving low-light operational capabilities.

Senop as well as other night vision goggles OEM relies on Photonis products to meet this demand quickly and effectively, reinforcing the importance of Exosens fast delivery capabilities. With over 40 years of experience in image intensifier technology, Exosens has established itself as the strategic supplier to NATO member states and their allies.

Exosens: Technology enhancing military performance 

With Senop’s high-quality casings and ergonomic designs combined with Exosens’ state-of-the-art night vision technology, the result provides a significant advantage on the battlefield Photonis’ 4G tubes provide exceptional visibility at very low light levels (to Night Level 5) and the compact, lightweight structure of the EVA M makes it ideal for the mobility of soldiers on operations.

Innovation is at the heart of our strategy,” said Exosens CEO, Jérôme Cerisier, “We are committed to providing armed forces with night vision technologies that not only meet but exceed current operational requirements, ensuring tactical superiority on the battlefield.” 

With a constant commitment to innovation and R&D, Exosens continues to anticipate the future needs of armed forces by developing reliable solutions that meet the most stringent MIL-SPEC standards.

Exosens will publish its full-year 2024 results on 3 March 2025, before market opening.
 

Download the Press release (EN)